Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses

Background Glucocorticoids (GC) are the most commonly used antiinflammatory drugs in dermatology. The actions of GCs are mediated by the glucocorticoid receptor (GR). Alternative splicing of GR mRNA gives rise to different isoforms, GRα and GRβ being the most important. GRβ antagonizes the activity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EJD. European journal of dermatology 2016, Vol.26 (1), p.21-27
Hauptverfasser: Kubin, Minna E., Hägg, Päivi M., Kokkonen, Nina, Väyrynen, Juha P., Haapasaari, Kirsi-Maria, Moilanen, Jyri, Kallioinen, Matti, Hurskainen, Tiina, Tasanen, Kaisa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27
container_issue 1
container_start_page 21
container_title EJD. European journal of dermatology
container_volume 26
creator Kubin, Minna E.
Hägg, Päivi M.
Kokkonen, Nina
Väyrynen, Juha P.
Haapasaari, Kirsi-Maria
Moilanen, Jyri
Kallioinen, Matti
Hurskainen, Tiina
Tasanen, Kaisa
description Background Glucocorticoids (GC) are the most commonly used antiinflammatory drugs in dermatology. The actions of GCs are mediated by the glucocorticoid receptor (GR). Alternative splicing of GR mRNA gives rise to different isoforms, GRα and GRβ being the most important. GRβ antagonizes the activity of GRα and its up-regulation has been associated with glucocorticoid insensitivity in several non-cutaneous inflammatory diseases. Methods Using immunohistochemical stainings, we analyzed the expression of GRα and GRβ in lesional skin samples of patients with atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus.We also conducted a study of 13 severe atopic patients to investigate the effect of prednisolone treatment on the expression of GR isoforms using quantitative PCR, western blot and immunohistochemical analysis. Results GRα and GRβ were expressed in atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus. Our novel finding was that GRα is abundant in keratinocytes and cutaneous neutrophils. Nuclear staining of both GRα and GRβ was strongest in keratinocytes of patients with lichen ruber planus, whereas the least nuclear positivity was detected in keratinocytes of patients with atopic dermatitis. In severe atopic dermatitis GRα and GRβ were expressed in both peripheral blood mononuclear cells and the skin. The expression of GRα and GRβ varied during prednisolone therapy but the changes were not related to treatment response or GC insensitivity. Conclusion GRα and GRβ are expressed in inflammatory dermatoses. In severe atopic dermatitis the increased expression of GRβ mRNA is not connected to insensitivity against prednisolone treatment.
doi_str_mv 10.1684/ejd.2015.2691
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1777488121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1777488121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-64655d274c274b145e4251258490e5348b9396d1470bc509f7f2688eb3d1487d3</originalsourceid><addsrcrecordid>eNp1kMtKxDAUhoMojo4u3UqXblpzbZKlDDoKAwOi69Amp9KhN5MpOI-lD-IzmTKjOyEhPzkfP5wPoSuCM5Irfgsbl1FMREZzTY7QGdGCphwTdhwzyWVKCKUzdB7CBmOKNVOnaEZzGWdanaH1shltb3u_rW1fu8SDhWHb-5Asn78_k6JzU_hKCg8JfAweQgCX1F08VVO0bRHZXeLATylAuEAnVdEEuDy8c_T6cP-yeExX6-XT4m6VWsboNs15LoSjktt4S8IFcCoIFYprDIJxVWqmc0e4xKUVWFeyorlSULL4p6Rjc3Sz7x18_z5C2Jq2DhaapuigH4MhUkquFKEkouketb4PwUNlBl-3hd8Zgs3k0ESHZnJoJoeRvz5Uj2UL7o_-lRaBbA-EOOrewJtNP_ourvtP4w9vrnv1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777488121</pqid></control><display><type>article</type><title>Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Kubin, Minna E. ; Hägg, Päivi M. ; Kokkonen, Nina ; Väyrynen, Juha P. ; Haapasaari, Kirsi-Maria ; Moilanen, Jyri ; Kallioinen, Matti ; Hurskainen, Tiina ; Tasanen, Kaisa</creator><creatorcontrib>Kubin, Minna E. ; Hägg, Päivi M. ; Kokkonen, Nina ; Väyrynen, Juha P. ; Haapasaari, Kirsi-Maria ; Moilanen, Jyri ; Kallioinen, Matti ; Hurskainen, Tiina ; Tasanen, Kaisa</creatorcontrib><description>Background Glucocorticoids (GC) are the most commonly used antiinflammatory drugs in dermatology. The actions of GCs are mediated by the glucocorticoid receptor (GR). Alternative splicing of GR mRNA gives rise to different isoforms, GRα and GRβ being the most important. GRβ antagonizes the activity of GRα and its up-regulation has been associated with glucocorticoid insensitivity in several non-cutaneous inflammatory diseases. Methods Using immunohistochemical stainings, we analyzed the expression of GRα and GRβ in lesional skin samples of patients with atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus.We also conducted a study of 13 severe atopic patients to investigate the effect of prednisolone treatment on the expression of GR isoforms using quantitative PCR, western blot and immunohistochemical analysis. Results GRα and GRβ were expressed in atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus. Our novel finding was that GRα is abundant in keratinocytes and cutaneous neutrophils. Nuclear staining of both GRα and GRβ was strongest in keratinocytes of patients with lichen ruber planus, whereas the least nuclear positivity was detected in keratinocytes of patients with atopic dermatitis. In severe atopic dermatitis GRα and GRβ were expressed in both peripheral blood mononuclear cells and the skin. The expression of GRα and GRβ varied during prednisolone therapy but the changes were not related to treatment response or GC insensitivity. Conclusion GRα and GRβ are expressed in inflammatory dermatoses. In severe atopic dermatitis the increased expression of GRβ mRNA is not connected to insensitivity against prednisolone treatment.</description><identifier>ISSN: 1167-1122</identifier><identifier>EISSN: 1952-4013</identifier><identifier>DOI: 10.1684/ejd.2015.2691</identifier><identifier>PMID: 26711698</identifier><language>eng</language><publisher>Paris: John Libbey Eurotext</publisher><subject>Adult ; Dermatitis - drug therapy ; Dermatitis - metabolism ; Dermatitis, Atopic - drug therapy ; Dermatitis, Atopic - metabolism ; Dermatology ; Drug Resistance ; Eczema - metabolism ; Female ; Glucocorticoids - therapeutic use ; Humans ; Immunohistochemistry ; Investigative Report ; Keratinocytes - metabolism ; Lichen Planus - metabolism ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neurodermatitis - metabolism ; Neutrophils - metabolism ; Prednisolone - therapeutic use ; Receptors, Glucocorticoid - metabolism ; RNA, Messenger - metabolism ; Skin - metabolism ; Up-Regulation ; Young Adult</subject><ispartof>EJD. European journal of dermatology, 2016, Vol.26 (1), p.21-27</ispartof><rights>John Libbey Eurotext 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-64655d274c274b145e4251258490e5348b9396d1470bc509f7f2688eb3d1487d3</citedby><cites>FETCH-LOGICAL-c332t-64655d274c274b145e4251258490e5348b9396d1470bc509f7f2688eb3d1487d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1684/ejd.2015.2691$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1684/ejd.2015.2691$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26711698$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kubin, Minna E.</creatorcontrib><creatorcontrib>Hägg, Päivi M.</creatorcontrib><creatorcontrib>Kokkonen, Nina</creatorcontrib><creatorcontrib>Väyrynen, Juha P.</creatorcontrib><creatorcontrib>Haapasaari, Kirsi-Maria</creatorcontrib><creatorcontrib>Moilanen, Jyri</creatorcontrib><creatorcontrib>Kallioinen, Matti</creatorcontrib><creatorcontrib>Hurskainen, Tiina</creatorcontrib><creatorcontrib>Tasanen, Kaisa</creatorcontrib><title>Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses</title><title>EJD. European journal of dermatology</title><addtitle>Eur J Dermatol</addtitle><addtitle>Eur J Dermatol</addtitle><description>Background Glucocorticoids (GC) are the most commonly used antiinflammatory drugs in dermatology. The actions of GCs are mediated by the glucocorticoid receptor (GR). Alternative splicing of GR mRNA gives rise to different isoforms, GRα and GRβ being the most important. GRβ antagonizes the activity of GRα and its up-regulation has been associated with glucocorticoid insensitivity in several non-cutaneous inflammatory diseases. Methods Using immunohistochemical stainings, we analyzed the expression of GRα and GRβ in lesional skin samples of patients with atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus.We also conducted a study of 13 severe atopic patients to investigate the effect of prednisolone treatment on the expression of GR isoforms using quantitative PCR, western blot and immunohistochemical analysis. Results GRα and GRβ were expressed in atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus. Our novel finding was that GRα is abundant in keratinocytes and cutaneous neutrophils. Nuclear staining of both GRα and GRβ was strongest in keratinocytes of patients with lichen ruber planus, whereas the least nuclear positivity was detected in keratinocytes of patients with atopic dermatitis. In severe atopic dermatitis GRα and GRβ were expressed in both peripheral blood mononuclear cells and the skin. The expression of GRα and GRβ varied during prednisolone therapy but the changes were not related to treatment response or GC insensitivity. Conclusion GRα and GRβ are expressed in inflammatory dermatoses. In severe atopic dermatitis the increased expression of GRβ mRNA is not connected to insensitivity against prednisolone treatment.</description><subject>Adult</subject><subject>Dermatitis - drug therapy</subject><subject>Dermatitis - metabolism</subject><subject>Dermatitis, Atopic - drug therapy</subject><subject>Dermatitis, Atopic - metabolism</subject><subject>Dermatology</subject><subject>Drug Resistance</subject><subject>Eczema - metabolism</subject><subject>Female</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Investigative Report</subject><subject>Keratinocytes - metabolism</subject><subject>Lichen Planus - metabolism</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neurodermatitis - metabolism</subject><subject>Neutrophils - metabolism</subject><subject>Prednisolone - therapeutic use</subject><subject>Receptors, Glucocorticoid - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Skin - metabolism</subject><subject>Up-Regulation</subject><subject>Young Adult</subject><issn>1167-1122</issn><issn>1952-4013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKxDAUhoMojo4u3UqXblpzbZKlDDoKAwOi69Amp9KhN5MpOI-lD-IzmTKjOyEhPzkfP5wPoSuCM5Irfgsbl1FMREZzTY7QGdGCphwTdhwzyWVKCKUzdB7CBmOKNVOnaEZzGWdanaH1shltb3u_rW1fu8SDhWHb-5Asn78_k6JzU_hKCg8JfAweQgCX1F08VVO0bRHZXeLATylAuEAnVdEEuDy8c_T6cP-yeExX6-XT4m6VWsboNs15LoSjktt4S8IFcCoIFYprDIJxVWqmc0e4xKUVWFeyorlSULL4p6Rjc3Sz7x18_z5C2Jq2DhaapuigH4MhUkquFKEkouketb4PwUNlBl-3hd8Zgs3k0ESHZnJoJoeRvz5Uj2UL7o_-lRaBbA-EOOrewJtNP_ourvtP4w9vrnv1</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Kubin, Minna E.</creator><creator>Hägg, Päivi M.</creator><creator>Kokkonen, Nina</creator><creator>Väyrynen, Juha P.</creator><creator>Haapasaari, Kirsi-Maria</creator><creator>Moilanen, Jyri</creator><creator>Kallioinen, Matti</creator><creator>Hurskainen, Tiina</creator><creator>Tasanen, Kaisa</creator><general>John Libbey Eurotext</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2016</creationdate><title>Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses</title><author>Kubin, Minna E. ; Hägg, Päivi M. ; Kokkonen, Nina ; Väyrynen, Juha P. ; Haapasaari, Kirsi-Maria ; Moilanen, Jyri ; Kallioinen, Matti ; Hurskainen, Tiina ; Tasanen, Kaisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-64655d274c274b145e4251258490e5348b9396d1470bc509f7f2688eb3d1487d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Dermatitis - drug therapy</topic><topic>Dermatitis - metabolism</topic><topic>Dermatitis, Atopic - drug therapy</topic><topic>Dermatitis, Atopic - metabolism</topic><topic>Dermatology</topic><topic>Drug Resistance</topic><topic>Eczema - metabolism</topic><topic>Female</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Investigative Report</topic><topic>Keratinocytes - metabolism</topic><topic>Lichen Planus - metabolism</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neurodermatitis - metabolism</topic><topic>Neutrophils - metabolism</topic><topic>Prednisolone - therapeutic use</topic><topic>Receptors, Glucocorticoid - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Skin - metabolism</topic><topic>Up-Regulation</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kubin, Minna E.</creatorcontrib><creatorcontrib>Hägg, Päivi M.</creatorcontrib><creatorcontrib>Kokkonen, Nina</creatorcontrib><creatorcontrib>Väyrynen, Juha P.</creatorcontrib><creatorcontrib>Haapasaari, Kirsi-Maria</creatorcontrib><creatorcontrib>Moilanen, Jyri</creatorcontrib><creatorcontrib>Kallioinen, Matti</creatorcontrib><creatorcontrib>Hurskainen, Tiina</creatorcontrib><creatorcontrib>Tasanen, Kaisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>EJD. European journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kubin, Minna E.</au><au>Hägg, Päivi M.</au><au>Kokkonen, Nina</au><au>Väyrynen, Juha P.</au><au>Haapasaari, Kirsi-Maria</au><au>Moilanen, Jyri</au><au>Kallioinen, Matti</au><au>Hurskainen, Tiina</au><au>Tasanen, Kaisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses</atitle><jtitle>EJD. European journal of dermatology</jtitle><stitle>Eur J Dermatol</stitle><addtitle>Eur J Dermatol</addtitle><date>2016</date><risdate>2016</risdate><volume>26</volume><issue>1</issue><spage>21</spage><epage>27</epage><pages>21-27</pages><issn>1167-1122</issn><eissn>1952-4013</eissn><abstract>Background Glucocorticoids (GC) are the most commonly used antiinflammatory drugs in dermatology. The actions of GCs are mediated by the glucocorticoid receptor (GR). Alternative splicing of GR mRNA gives rise to different isoforms, GRα and GRβ being the most important. GRβ antagonizes the activity of GRα and its up-regulation has been associated with glucocorticoid insensitivity in several non-cutaneous inflammatory diseases. Methods Using immunohistochemical stainings, we analyzed the expression of GRα and GRβ in lesional skin samples of patients with atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus.We also conducted a study of 13 severe atopic patients to investigate the effect of prednisolone treatment on the expression of GR isoforms using quantitative PCR, western blot and immunohistochemical analysis. Results GRα and GRβ were expressed in atopic dermatitis, lichen ruber planus, eczema nummulare and lichen simplex chronicus. Our novel finding was that GRα is abundant in keratinocytes and cutaneous neutrophils. Nuclear staining of both GRα and GRβ was strongest in keratinocytes of patients with lichen ruber planus, whereas the least nuclear positivity was detected in keratinocytes of patients with atopic dermatitis. In severe atopic dermatitis GRα and GRβ were expressed in both peripheral blood mononuclear cells and the skin. The expression of GRα and GRβ varied during prednisolone therapy but the changes were not related to treatment response or GC insensitivity. Conclusion GRα and GRβ are expressed in inflammatory dermatoses. In severe atopic dermatitis the increased expression of GRβ mRNA is not connected to insensitivity against prednisolone treatment.</abstract><cop>Paris</cop><pub>John Libbey Eurotext</pub><pmid>26711698</pmid><doi>10.1684/ejd.2015.2691</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1167-1122
ispartof EJD. European journal of dermatology, 2016, Vol.26 (1), p.21-27
issn 1167-1122
1952-4013
language eng
recordid cdi_proquest_miscellaneous_1777488121
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Dermatitis - drug therapy
Dermatitis - metabolism
Dermatitis, Atopic - drug therapy
Dermatitis, Atopic - metabolism
Dermatology
Drug Resistance
Eczema - metabolism
Female
Glucocorticoids - therapeutic use
Humans
Immunohistochemistry
Investigative Report
Keratinocytes - metabolism
Lichen Planus - metabolism
Male
Medicine
Medicine & Public Health
Middle Aged
Neurodermatitis - metabolism
Neutrophils - metabolism
Prednisolone - therapeutic use
Receptors, Glucocorticoid - metabolism
RNA, Messenger - metabolism
Skin - metabolism
Up-Regulation
Young Adult
title Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T00%3A30%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucocorticoid%20receptors%20GR%CE%B1%20and%20GR%CE%B2%20are%20expressed%20in%20inflammatory%20dermatoses&rft.jtitle=EJD.%20European%20journal%20of%20dermatology&rft.au=Kubin,%20Minna%20E.&rft.date=2016&rft.volume=26&rft.issue=1&rft.spage=21&rft.epage=27&rft.pages=21-27&rft.issn=1167-1122&rft.eissn=1952-4013&rft_id=info:doi/10.1684/ejd.2015.2691&rft_dat=%3Cproquest_cross%3E1777488121%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777488121&rft_id=info:pmid/26711698&rfr_iscdi=true